Cargando…
Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer
Whether germline multigene panel testing (MGPT) should be performed in all individuals with colorectal cancer (CRC) remains uncertain. Therefore, we aimed to determine the yield and potential clinical impact of MGPT across a large, diverse CRC cohort. METHODS: This was a retrospective cohort study o...
Autores principales: | Coughlin, Sarah E., Heald, Brandie, Clark, Dana Farengo, Nielsen, Sarah M., Hatchell, Kathryn E., Esplin, Edward D., Katona, Bryson W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812641/ https://www.ncbi.nlm.nih.gov/pubmed/36370464 http://dx.doi.org/10.1200/PO.22.00517 |
Ejemplares similares
-
Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer
por: Clark, Dana Farengo, et al.
Publicado: (2020) -
Ashkenazi Jewish and Other White APC I1307K Carriers Are at Higher Risk for Multiple Cancers
por: Forkosh, Esther, et al.
Publicado: (2022) -
Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer
por: Moretz, Chad, et al.
Publicado: (2022) -
Multigene Panel Testing in a Large Cohort of Adults With Epilepsy: Diagnostic Yield and Clinically Actionable Genetic Findings
por: McKnight, Dianalee, et al.
Publicado: (2021) -
Underdiagnosis of Hereditary Colorectal Cancers Among Medicare Patients: Genetic Testing Criteria for Lynch Syndrome Miss the Mark
por: Muller, Charles, et al.
Publicado: (2021)